FDA Medical Device News | Approvals, Clearances & Recalls

Follow the latest FDA medical device news from Medical Device News Magazine, including 510(k) clearances, Premarket Approval (PMA) decisions, De Novo classifications, medical device recalls, safety communications, regulatory updates, and newly authorized medical technologies entering the U.S. healthcare market.

Our FDA medical device coverage keeps healthcare professionals, medical device executives, researchers, investors, and industry leaders informed about important regulatory decisions that can influence patient care, product development, commercialization, and the future of medical technology.

FDA Medical Device Approvals & 510(k) Clearances

Stay informed about the latest medical technologies reviewed by the U.S. Food and Drug Administration, including devices receiving 510(k) clearance, high-risk technologies receiving Premarket Approval (PMA), and novel technologies proceeding through the De Novo classification pathway.

Medical Device News Magazine reports on regulatory milestones involving innovative diagnostic technologies, cardiovascular and vascular devices, surgical systems, medical imaging equipment, orthopedic technologies, neurological devices, digital health solutions, artificial intelligence-enabled technologies, remote patient monitoring systems, and other emerging medical devices.

Our coverage goes beyond announcing an FDA decision. We examine what a clearance or approval means for the technology, its manufacturer, physicians, healthcare organizations, patients, and the broader medical device marketplace.

Medical Device Recalls, Safety Alerts & FDA Communications

FDA oversight continues after a medical device reaches the market. Medical Device News Magazine follows significant medical device recalls, corrections, removals, early alerts, safety communications, and other post-market developments that healthcare professionals and industry stakeholders need to know.

We report on important safety issues involving medical devices and technologies and provide timely information about manufacturer actions and FDA communications that may affect physicians, healthcare facilities, patients, distributors, and medical device companies.

Coverage may include newly identified device risks, product corrections, software issues, labeling changes, manufacturing concerns, updated instructions for use, adverse-event concerns, and other developments that could influence the safe and effective use of medical technologies.

FDA Regulatory News & Policy Developments

Medical device regulation is constantly evolving as new technologies enter clinical practice. Medical Device News Magazine follows significant FDA regulatory developments, guidance, policies, programs, and initiatives affecting medical device manufacturers and the healthcare community.

From artificial intelligence and software-enabled medical technologies to implantable devices, diagnostics, robotics, digital health, and next-generation treatment platforms, regulatory policy can have a major impact on how quickly new technologies move from development to clinical use.

We help readers understand these developments and their potential implications for medical device innovation, regulatory strategy, commercialization, and patient access.

Following Medical Technologies From Innovation to Patient Care

An FDA clearance, approval, authorization, safety communication, or recall can represent an important milestone in the lifecycle of a medical technology.

Medical Device News Magazine follows these developments to provide readers with a broader understanding of which medical technologies are advancing, how the regulatory landscape is changing, and what these developments could mean for healthcare delivery and patient care.

Whether you are a physician evaluating emerging technologies, a medical device executive following regulatory developments, a researcher monitoring innovation, or an investor assessing the medical technology marketplace, Medical Device News Magazine provides timely FDA medical device news and regulatory insights to help you stay informed about the technologies shaping the future of healthcare.

Centauri Therapeutics granted FDA QIDP status for CTX-187 treatment of Gram-negative bacterial infections

Dr. Debra Barker, Chief Medical Officer, Centauri Therapeutics, said: “This designation from the FDA will be invaluable as we continue to advance toward first in-human trials for CTX-187. The recognition of the potential value of our technology further underpins our belief in its potential to transform treatment paradigms for Gram-negative bacterial infections, filling an urgently needed gap in the market for new and effective treatment options for clinically vulnerable patients.”